Nuveen’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.5M | Sell |
121,079
-12,904
| -10% | -$2.3M | 0.01% | 1069 |
|
|
2026
Q1 | $23.1M | Buy |
133,983
+7,163
| +6% | +$1.33M | 0.01% | 1049 |
|
|
2025
Q4 | $25.3M | Sell |
126,820
-25,457
| -17% | -$4.62M | 0.01% | 1003 |
|
|
2025
Q3 | $23.8M | Sell |
152,277
-650
| -0.4% | -$103K | 0.01% | 1040 |
|
|
2025
Q2 | $23.2M | Buy |
152,927
+29,767
| +24% | +$3.97M | 0.01% | 1010 |
|
|
2025
Q1 | $18.5M | Sell |
123,160
-3,907
| -3% | -$655K | 0.01% | 1169 |
|
|
2024
Q4 | $23.5M | Sell |
127,067
-1,770
| -1% | -$341K | 0.01% | 1077 |
|
|
2024
Q3 | $25.4M | Sell |
128,837
-1,162
| -0.9% | -$241K | 0.01% | 1027 |
|
|
2024
Q2 | $26.9M | Sell |
129,999
-4,578
| -3% | -$1.04M | 0.01% | 938 |
|
|
2024
Q1 | $36.5M | Sell |
134,577
-46,173
| -26% | -$11M | 0.01% | 791 |
|
|
2023
Q4 | $42.7M | Buy |
180,750
+109
| +0.1% | +$21.4K | 0.01% | 679 |
|
|
2023
Q3 | $35.4M | Sell |
180,641
-1,711
| -0.9% | -$351K | 0.01% | 718 |
|
|
2023
Q2 | $38.3M | Sell |
182,352
-34,393
| -16% | -$6.84M | 0.01% | 684 |
|
|
2023
Q1 | $43.7M | Buy |
216,745
+8,337
| +4% | +$1.89M | 0.02% | 606 |
|
|
2022
Q4 | $45.4M | Sell |
208,408
-30,564
| -13% | -$6.67M | 0.02% | 574 |
|
|
2022
Q3 | $47M | Sell |
238,972
-70,742
| -23% | -$15.3M | 0.02% | 541 |
|
|
2022
Q2 | $66.3M | Sell |
309,714
-32,118
| -9% | -$7.85M | 0.03% | 459 |
|
|
2022
Q1 | $98M | Buy |
341,832
+68,471
| +25% | +$21.1M | 0.03% | 423 |
|
|
2021
Q4 | $103M | Buy |
273,361
+21,013
| +8% | +$8.16M | 0.03% | 434 |
|
|
2021
Q3 | $104M | Sell |
252,348
-31,205
| -11% | -$13M | 0.03% | 416 |
|
|
2021
Q2 | $105M | Buy |
283,553
+23,029
| +9% | +$7.69M | 0.03% | 460 |
|
|
2021
Q1 | $75.5M | Sell |
260,524
-4,447
| -2% | -$1.24M | 0.02% | 550 |
|
|
2020
Q4 | $66.2M | Buy |
264,971
+65,556
| +33% | +$15.6M | 0.02% | 568 |
|
|
2020
Q3 | $45.2M | Sell |
199,415
-7,118
| -3% | -$1.48M | 0.02% | 612 |
|
|
2020
Q2 | $36M | Sell |
206,533
-56,678
| -22% | -$9.05M | 0.01% | 687 |
|
|
2020
Q1 | $33.2M | Buy |
263,211
+113,343
| +76% | +$17M | 0.02% | 639 |
|
|
2019
Q4 | $22.9M | Sell |
149,868
-26,225
| -15% | -$3.63M | 0.01% | 1089 |
|
|
2019
Q3 | $23.3M | Sell |
176,093
-27,096
| -13% | -$3.63M | 0.01% | 1049 |
|
|
2019
Q2 | $28.8M | Buy |
203,189
+197,847
| +3,704% | +$26.8M | 0.01% | 958 |
|
|
2019
Q1 | $776K | Hold |
5,342
| – | – | ﹤0.01% | 778 |
|
|
2018
Q4 | $605K | Hold |
5,342
| – | – | ﹤0.01% | 791 |
|
|
2018
Q3 | $719K | Buy |
5,342
+554
| +12% | +$68.4K | ﹤0.01% | 796 |
|
|
2018
Q2 | $538K | Hold |
4,788
| – | – | ﹤0.01% | 860 |
|
|
2018
Q1 | $511K | Hold |
4,788
| – | – | ﹤0.01% | 887 |
|
|
2017
Q4 | $524K | Hold |
4,788
| – | – | ﹤0.01% | 886 |
|
|
2017
Q3 | $517K | Sell |
4,788
-474
| -9% | -$48.7K | ﹤0.01% | 901 |
|
|
2017
Q2 | $532K | Sell |
5,262
-13,968
| -73% | -$1.29M | ﹤0.01% | 915 |
|
|
2017
Q1 | $1.73M | Sell |
19,230
-3,632
| -16% | -$308K | 0.01% | 745 |
|
|
2016
Q4 | $1.74M | Sell |
22,862
-1,937
| -8% | -$147K | 0.01% | 932 |
|
|
2016
Q3 | $2.07M | Sell |
24,799
-32,300
| -57% | -$2.71M | 0.01% | 769 |
|
|
2016
Q2 | $4.71M | Buy |
57,099
+31,800
| +126% | +$2.62M | 0.03% | 510 |
|
|
2016
Q1 | $1.92M | Sell |
25,299
-12,200
| -33% | -$903K | 0.01% | 759 |
|
|
2015
Q4 | $3.02M | Buy |
37,499
+13,174
| +54% | +$950K | 0.02% | 621 |
|
|
2015
Q3 | $1.54M | Hold |
24,325
| – | – | 0.01% | 887 |
|
|
2015
Q2 | $1.71M | Hold |
24,325
| – | – | 0.01% | 900 |
|
|
2015
Q1 | $1.93M | Hold |
24,325
| – | – | 0.01% | 865 |
|
|
2014
Q4 | $1.55M | Hold |
24,325
| – | – | 0.01% | 982 |
|
|
2014
Q3 | $1.45M | Sell |
24,325
-152
| -0.6% | -$8.7K | 0.01% | 964 |
|
|
2014
Q2 | $1.31M | Sell |
24,477
-1,473
| -6% | -$80.8K | 0.01% | 1020 |
|
|
2014
Q1 | $1.57M | Sell |
25,950
-231
| -0.9% | -$13.5K | 0.01% | 913 |
|
|
2013
Q4 | $1.39M | Sell |
26,181
-23,265
| -47% | -$1.17M | 0.01% | 940 |
|
|
2013
Q3 | $2.29M | Buy |
49,446
+26,632
| +117% | +$1.22M | 0.01% | 743 |
|
|
2013
Q2 | $936K | Buy |
+22,814
| New | +$977K | 0.01% | 1062 |
|
Other funds holding CRL
AI
Nuveen's CRL Position: Q2 2026 in Review
Nuveen reduced its Charles River Laboratories (CRL) stake by 9.6% in Q2 2026, selling an estimated $2.3M and leaving 121,079 shares worth $27.5M. The position accounts for 0.01% of the portfolio, ranked #1069.
Nuveen first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $105M in Q2 2021. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Nuveen held 121,079 shares of Charles River Laboratories worth $27.5M as of Q2 2026.
- Nuveen sold 12,904 Charles River Laboratories shares in Q2 2026, an estimated $2.3M.
- Charles River Laboratories made up 0.01% of Nuveen's portfolio in Q2 2026, its #1069 holding.
- Nuveen first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Charles River Laboratories position peaked at $105M in Q2 2021.
- 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.